Loading...

Association between Intra-Circuit Activated Clotting Time and Incidence of Bleeding Complications during Continuous Renal Replacement Therapy using Nafamostat Mesilate: a Retrospective Pilot Observational Study

It has been proposed that anticoagulant activity during continuous renal replacement therapy with nafamostat mesilate can be monitored by using intra-circuit activated clotting time. However, it is still unclear whether activated clotting time would be useful for this purpose. We conducted a retrosp...

Full description

Saved in:
Bibliographic Details
Published in:Kobe J Med Sci
Main Authors: MIYATAKE, YUJI, MAKINO, SHOHEI, KUBOTA, KENTA, EGI, MORITOKI, MIZOBUCHI, SATOSHI
Format: Artigo
Language:Inglês
Published: Kobe University School Of Medicine 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824928/
https://ncbi.nlm.nih.gov/pubmed/29434171
Tags: Add Tag
No Tags, Be the first to tag this record!